Writer
Abhinay Wadekar
BPharm
12
Articles written or reviewed
About Abhinay
Abhinay Wadekar (BPharm) is a writer at Pharmacally, with 12 published articles, each checked against primary sources by our editorial team.
On Pharmacally
Articles by Abhinay Wadekar
ResearchSemaglutide and Eye Health: A Look at NAION Risk
Drugs Safety AlertThe Truth about “Ozempic Penis”: What Men Should Know About Semaglutide and Perceived Size Changes
Clinical TrialsFDA Approves Rybelsus Oral Semaglutide for Cardiovascular Risk Reduction in Type 2 Diabetes: Insights from the SOUL Trial
Clinical TrialsInnovent and Lilly’s Mazdutide Outperforms Semaglutide in Phase 3 DREAMS-3 Trial with Superior Glycemic Control and Weight Loss
Clinical TrialsLong-Term SELECT Trial: Semaglutide Cuts Cardiovascular Events by 20% beyond Weight Loss
Clinical TrialsAlector Faces Major Setback as Latozinemab Fails Phase 3 Trial, Cuts 50% Staff
Clinical TrialsFirst Successful Restoration of Central Vision in Dry AMD Using Subretinal Implant, Study Published in NEJM
Health TidingsFDA Issues Complete Response Letter to Xspray Pharma’s Dasynoc Due to GMP Concerns: Impact on Leukemia Treatment Approval
New Drug ApprovalFDA Approves Libtayo® (cemiplimab-rwlc) for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma: Clinical Evidence and Expert InsightsOur people
More from our experts
View our team

A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala